SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial

BACKGROUND: Sarpogrelate is expected to reduce restenosis by protecting blood vessels from oxidative stress and vascular endothelial dysfunction as well as by acting as an antiplatelet agent after endovascular treatment (EVT). This trial was designed to compare aspirin plus sustained-release (SR) sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Sanghyun, Lee, Joongyub, Min, Seung-Kee, Ha, Jongwon, Min, Sang-il, Kim, Song-Yi, Cho, Min-Ji, Cho, Sungsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610452/
https://www.ncbi.nlm.nih.gov/pubmed/28938905
http://dx.doi.org/10.1186/s13063-017-2155-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610452/
https://www.ncbi.nlm.nih.gov/pubmed/28938905
http://dx.doi.org/10.1186/s13063-017-2155-5

Ejemplares similares